Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Long-term quality of life and postthrombotic syndrome in women after an episode of venous thromboembolism.

Ljungqvist M, Holmström M, Kieler H, Lärfars G.

Phlebology. 2018 May;33(4):234-241. doi: 10.1177/0268355517698620. Epub 2017 Mar 16.

PMID:
28956493
2.

High adherence to the 'Wise List' treatment recommendations in Stockholm: a 15-year retrospective review of a multifaceted approach promoting rational use of medicines.

Eriksen J, Gustafsson LL, Ateva K, Bastholm-Rahmner P, Ovesjö ML, Jirlow M, Juhasz-Haverinen M, Lärfars G, Malmström RE, Wettermark B, Andersén-Karlsson E; Stockholm DTC.

BMJ Open. 2017 May 2;7(4):e014345. doi: 10.1136/bmjopen-2016-014345.

3.

Cardiovascular disease and mortality after a first episode of venous thromboembolism in young and middle-aged women.

Ljungqvist M, Holmström M, Kieler H, Odeberg J, Lärfars G.

Thromb Res. 2016 Feb;138:80-85. doi: 10.1016/j.thromres.2015.11.039. Epub 2015 Dec 2.

PMID:
26826509
4.

F11 is associated with recurrent VTE in women. A prospective cohort study.

Bruzelius M, Ljungqvist M, Bottai M, Bergendal A, Strawbridge RJ, Holmström M, Silveira A, Kieler H, Hamsten A, Lärfars G, Odeberg J.

Thromb Haemost. 2016 Jan;115(2):406-14. doi: 10.1160/TH15-06-0459. Epub 2015 Oct 1.

PMID:
26423325
5.

The importance of the costoclavicular space in upper limb primary deep vein thrombosis, a study with magnetic resonance imaging (MRI) technique enhanced by a blood pool agent.

Arnhjort T, Nordberg J, Delle M, Borgis CJ, Rosfors S, Lärfars G.

Eur J Intern Med. 2014 Jul;25(6):545-9. doi: 10.1016/j.ejim.2014.05.005. Epub 2014 May 27.

PMID:
24873726
6.

Risk factors for recurrent venous thromboembolism in young and middle-aged women.

Ljungqvist M, Sonnevi K, Bergendal A, Holmström M, Kieler H, Lärfars G.

Thromb Res. 2014 May;133(5):762-7. doi: 10.1016/j.thromres.2014.02.017. Epub 2014 Feb 26.

PMID:
24613699
7.

Self-reported family history in estimating the risk of hormone, surgery and cast related VTE in women.

Sonnevi K, Bergendal A, Adami J, Lärfars G, Kieler H.

Thromb Res. 2013 Aug;132(2):164-9. doi: 10.1016/j.thromres.2013.06.003. Epub 2013 Jun 22.

PMID:
23800637
8.

Non-steroidal anti-inflammatory drugs and venous thromboembolism in women.

Bergendal A, Adami J, Bahmanyar S, Hedenmalm K, Lärfars G, Persson I, Sundström A, Kieler H.

Pharmacoepidemiol Drug Saf. 2013 Jun;22(6):658-66.

PMID:
23508885
9.

Obesity and thrombin-generation profiles in women with venous thromboembolism.

Sonnevi K, Tchaikovski SN, Holmström M, Antovic JP, Bremme K, Rosing J, Lärfars G.

Blood Coagul Fibrinolysis. 2013 Jul;24(5):547-53. doi: 10.1097/MBC.0b013e32835f93d5.

PMID:
23470648
10.

Risk factors for venous thromboembolism in pre-and postmenopausal women.

Bergendal A, Bremme K, Hedenmalm K, Lärfars G, Odeberg J, Persson I, Sundström A, Kieler H.

Thromb Res. 2012 Oct;130(4):596-601. doi: 10.1016/j.thromres.2012.05.024. Epub 2012 Jun 14.

PMID:
22704078
11.

Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.

Sonnevi K, Tchaikovski SN, Holmström M, Rosing J, Bremme K, Lärfars G.

Thromb Haemost. 2011 Nov;106(5):901-7. doi: 10.1160/TH11-04-0254. Epub 2011 Sep 22.

PMID:
21947267
12.

Deep venous thrombosis after surgery for Achilles tendon rupture: a provoked transient event with minor long-term sequelae.

Persson LM, Lapidus LJ, Lärfars G, Rosfors S.

J Thromb Haemost. 2011 Aug;9(8):1493-9. doi: 10.1111/j.1538-7836.2011.04376.x.

13.

Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.

Farahnak P, Lärfars G, Sten-Linder M, Nilsson IL.

J Clin Endocrinol Metab. 2011 Jul;96(7):2112-8. doi: 10.1210/jc.2011-0238. Epub 2011 May 18.

PMID:
21593116
14.

Bleeding from gastrointestinal angioectasias is not related to bleeding disorders - a case control study.

Höög CM, Broström O, Lindahl TL, Hillarp A, Lärfars G, Sjöqvist U.

BMC Gastroenterol. 2010 Sep 28;10:113. doi: 10.1186/1471-230X-10-113.

15.

A follow-up study of the fate of small asymptomatic deep venous thromboses.

Rosfors S, Persson LM, Lärfars G, Lapidus LJ.

Thromb J. 2010 Feb 12;8:4. doi: 10.1186/1477-9560-8-4.

16.

[New drug in atrial fibrillation--how does it function in regular health care?].

Holmström M, Johnsson H, Lärfars G, Malmström R, Hjemdahl P.

Lakartidningen. 2009 Nov 4-12;106(45):3019-20. Swedish. No abstract available.

PMID:
19998831
17.

Asymptomatic deep venous thrombosis is associated with a low risk of post-thrombotic syndrome.

Persson LM, Lapidus LJ, Lärfars G, Rosfors S.

Eur J Vasc Endovasc Surg. 2009 Aug;38(2):229-33. doi: 10.1016/j.ejvs.2008.03.021. Epub 2009 May 30.

18.

The use of D-dimer testing and Wells score in patients with high probability for acute pulmonary embolism.

Söderberg M, Brohult J, Jorfeldt L, Lärfars G.

J Eval Clin Pract. 2009 Feb;15(1):129-33. doi: 10.1111/j.1365-2753.2008.00967.x. Epub 2008 Aug 28.

PMID:
18759753
19.

Evaluation of Wells score and repeated D-dimer in diagnosing venous thromboembolism.

Ljungqvist M, Söderberg M, Moritz P, Ahlgren A, Lärfars G.

Eur J Intern Med. 2008 Jun;19(4):285-8. doi: 10.1016/j.ejim.2007.08.007. Epub 2008 Jan 30.

PMID:
18471679
20.

TPO, but not soluble-IL-6 receptor, levels increase after anagrelide treatment of thrombocythemia in chronic myeloproliferative disorders.

Palmblad J, Björkholm M, Kutti J, Lärfars G, Löfvenberg E, Markevärn B, Merup M, Mauritzson N, Westin J, Samuelsson J, Birgegård G.

Int J Med Sci. 2008 Apr 13;5(2):87-91.

21.

Prolonged thromboprophylaxis with Dalteparin during immobilization after ankle fracture surgery: a randomized placebo-controlled, double-blind study.

Lapidus LJ, Ponzer S, Elvin A, Levander C, Lärfars G, Rosfors S, de Bri E.

Acta Orthop. 2007 Aug;78(4):528-35.

PMID:
17966008
22.

Primary deep vein thrombosis in the upper limb: A retrospective study with emphasis on pathogenesis and late sequelae.

Arnhjort T, Persson LM, Rosfors S, Ludwigs U, Lärfars G.

Eur J Intern Med. 2007 Jul;18(4):304-8.

PMID:
17574105
23.

Addition of intravenous iron to epoetin beta increases hemoglobin response and decreases epoetin dose requirement in anemic patients with lymphoproliferative malignancies: a randomized multicenter study.

Hedenus M, Birgegård G, Näsman P, Ahlberg L, Karlsson T, Lauri B, Lundin J, Lärfars G, Osterborg A.

Leukemia. 2007 Apr;21(4):627-32. Epub 2007 Jan 25. Erratum in: Leukemia. 2008 Feb;22(2):462.

PMID:
17252006
24.

Prolonged thromboprophylaxis with dalteparin after surgical treatment of achilles tendon rupture: a randomized, placebo-controlled study.

Lapidus LJ, Rosfors S, Ponzer S, Levander C, Elvin A, Lärfars G, de Bri E.

J Orthop Trauma. 2007 Jan;21(1):52-7.

PMID:
17211270
25.

Initial symptoms in pulmonary embolism differ from those in pneumonia: a retrospective study during seven years.

Söderberg M, Hedström U, Sjunnesson M, Lärfars G, Jorup-Rönström C.

Eur J Emerg Med. 2006 Aug;13(4):225-9. Erratum in: Eur J Emerg Med. 2008 Jun;15(3):186.

PMID:
16816587
26.

Hemodynamic and morphologic evaluation of sequelae of primary upper extremity deep venous thromboses treated with anticoagulation.

Persson LM, Arnhjort T, Lärfars G, Rosfors S.

J Vasc Surg. 2006 Jun;43(6):1230-5; discussion 1235.

27.

Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months.

Schulman S, Lindmarker P, Holmström M, Lärfars G, Carlsson A, Nicol P, Svensson E, Ljungberg B, Viering S, Nordlander S, Leijd B, Jahed K, Hjorth M, Linder O, Beckman M.

J Thromb Haemost. 2006 Apr;4(4):734-42.

28.

A methodological study of computerized venous strain-gauge plethysmography of the upper extremities.

Persson LM, Arnhjort T, Haneby C, Lärfars G, Rosfors S.

Clin Physiol Funct Imaging. 2005 Sep;25(5):281-5.

PMID:
16117731
29.

Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders.

Birgegård G, Björkholm M, Kutti J, Lärfars G, Löfvenberg E, Markevärn B, Merup M, Palmblad J, Mauritzson N, Westin J, Samuelsson J.

Haematologica. 2004 May;89(5):520-7.

30.

Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients.

Karlsson K, Strömberg M, Liliemark J, Delannoy A, Johnson SA, Porwit A, Kimby E, Lärfars G, Cristiansen I, Nilsson G, Celsing F, Sundström G, Luthman M, Tidefelt U, Wallvik J, Juliusson G.

Br J Haematol. 2002 Mar;116(3):538-48.

PMID:
11849209
31.
32.

Electrochemical detection of nitric oxide production in human polymorphonuclear neutrophil leukocytes.

Lärfars G, Lantoine F, Devynck MA, Gyllenhammar H.

Scand J Clin Lab Invest. 1999 Aug;59(5):361-8.

PMID:
10533848
34.
35.

Activation of nitric oxide release and oxidative metabolism by leukotrienes B4, C4, and D4 in human polymorphonuclear leukocytes.

Lärfars G, Lantoine F, Devynck MA, Palmblad J, Gyllenhammar H.

Blood. 1999 Feb 15;93(4):1399-405.

36.
37.

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

Schulman S, Granqvist S, Holmström M, Carlsson A, Lindmarker P, Nicol P, Eklund SG, Nordlander S, Lärfars G, Leijd B, Linder O, Loogna E.

N Engl J Med. 1997 Feb 6;336(6):393-8.

38.

Fludarabine, as well as 2-chlorodeoxyadenosine, can induce eosinophilia during treatment of lymphoid malignancies.

Lärfars G, Udén-Blohmé AM, Samuelsson J.

Br J Haematol. 1996 Sep;94(4):709-12.

PMID:
8826898
40.

A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group.

Schulman S, Rhedin AS, Lindmarker P, Carlsson A, Lärfars G, Nicol P, Loogna E, Svensson E, Ljungberg B, Walter H.

N Engl J Med. 1995 Jun 22;332(25):1661-5.

Supplemental Content

Loading ...
Support Center